Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Zimmerman

Showing results (331-340 of 393) with videos related to

Pageof 40
Sort By:
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 21, 2018
Does diagnosing a patient with borderline personality disorder negatively impact patient satisfaction with the initial diagnostic evaluation?Mark Zimmerman, Patrick McGonigal, Sydney S Moon, et al.
Comprehensive Psychiatry|May 13, 2017
Delineating the joint hierarchical structure of clinical and personality disorders in an outpatient psychiatric sampleMiriam K Forbes, Roman Kotov, Camilo J Ruggero, et al.
International Journal of Geriatric Psychiatry|August 23, 2016
Inclusion/exclusion criteria in late life depression antidepressant efficacy trialsMark Zimmerman, Matthew D Multach, Heather L Clark, et al.
Journal of Affective Disorders|March 23, 2016
Variability in the substance use disorder exclusion criterion in antidepressant efficacy trialsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Mayo Clinic Proceedings|August 16, 2015
Have Treatment Studies of Depression Become Even Less Generalizable? A Review of the Inclusion and Exclusion Criteria Used in Placebo-Controlled Antidepressant Efficacy Trials Published During the Past 20 YearsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Depression and Anxiety|February 11, 2011
Diagnosing social anxiety disorder in the presence of obesity: implications for a proposed change in DSM-5Kristy L Dalrymple, Janine Galione, Joshua Hrabosky, et al.
Journal of Affective Disorders|November 8, 2015
Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labelingMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Journal of Clinical Psychopharmacology|February 6, 2016
Symptom Severity and the Generalizability of Antidepressant Efficacy Trials: Changes During the Past 20 YearsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Journal of Personality Assessment|November 15, 2021
Exploring the Optimal Factor Structure of the Five Facet Mindfulness Questionnaire: Associations Between Mindfulness Facets and Dimensions of PsychopathologyJoseph M Diehl, Craig Rodriguez-Seijas, Justine S Thompson, et al.
Journal of Psychiatric Research|October 30, 2012
A new type of scale for determining remission from depression: the Remission from Depression QuestionnaireMark Zimmerman, Jennifer H Martinez, Naureen Attiullah, et al.
Pageof 40

Showing results (331-340 of 393) with videos related to

Sort By:
Pageof 40
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 21, 2018
Does diagnosing a patient with borderline personality disorder negatively impact patient satisfaction with the initial diagnostic evaluation?Mark Zimmerman, Patrick McGonigal, Sydney S Moon, et al.
Comprehensive Psychiatry|May 13, 2017
Delineating the joint hierarchical structure of clinical and personality disorders in an outpatient psychiatric sampleMiriam K Forbes, Roman Kotov, Camilo J Ruggero, et al.
International Journal of Geriatric Psychiatry|August 23, 2016
Inclusion/exclusion criteria in late life depression antidepressant efficacy trialsMark Zimmerman, Matthew D Multach, Heather L Clark, et al.
Journal of Affective Disorders|March 23, 2016
Variability in the substance use disorder exclusion criterion in antidepressant efficacy trialsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Mayo Clinic Proceedings|August 16, 2015
Have Treatment Studies of Depression Become Even Less Generalizable? A Review of the Inclusion and Exclusion Criteria Used in Placebo-Controlled Antidepressant Efficacy Trials Published During the Past 20 YearsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Depression and Anxiety|February 11, 2011
Diagnosing social anxiety disorder in the presence of obesity: implications for a proposed change in DSM-5Kristy L Dalrymple, Janine Galione, Joshua Hrabosky, et al.
Journal of Affective Disorders|November 8, 2015
Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labelingMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Journal of Clinical Psychopharmacology|February 6, 2016
Symptom Severity and the Generalizability of Antidepressant Efficacy Trials: Changes During the Past 20 YearsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Journal of Personality Assessment|November 15, 2021
Exploring the Optimal Factor Structure of the Five Facet Mindfulness Questionnaire: Associations Between Mindfulness Facets and Dimensions of PsychopathologyJoseph M Diehl, Craig Rodriguez-Seijas, Justine S Thompson, et al.
Journal of Psychiatric Research|October 30, 2012
A new type of scale for determining remission from depression: the Remission from Depression QuestionnaireMark Zimmerman, Jennifer H Martinez, Naureen Attiullah, et al.
Pageof 40